Asfotase alfa has a limited effect in improving the bowed limbs in perinatal benign hypophosphatasia: A case report [PDF]
Masaki Matsushita +2 more
exaly +2 more sources
The Effect of Asfotase Alfa on Plasma and Urine Pyrophosphate Levels and Pseudofractures in a Patient With Adult-Onset Hypophosphatasia. [PDF]
Hypophosphatasia (HPP) is an inherited disease caused by variants of the ALPL gene encoding tissue‐nonspecific alkaline phosphatase. Adult‐onset HPP (adult HPP), known as a mild form of HPP, develops symptoms involving osteomalacia after the age of 18 ...
Hidaka N +14 more
europepmc +2 more sources
Asfotase alfa is a human recombinant enzyme replacement therapy for hypophosphatasia. We describe 6 adults who were treated with asfotase alfa for 61–68 months in a clinical trial (NCT01163149), after which asfotase alfa was discontinued for 15–48 months.
Cheryl Rockman-Greenberg +3 more
doaj +1 more source
Visualization of asfotase alfa-binding to sites of calcification in vivo
Flavia Amadeu de Oliveira +3 more
doaj +2 more sources
Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels [PDF]
Yasuhisa Ohata, Kenro Imaeda
exaly +2 more sources
Hypophosphatasia: from birth to adulthood [PDF]
Hypophosphatasia (HPP) is an inherited disease caused by a low activity of tissue-nonspecific alkaline phosphatase, a hydrolase that removes phosphate groups from many molecules.
Fernanda Salles Reis +1 more
doaj +1 more source
Improvement in quality of life after asfotase alfa treatment in adults with pediatric-onset hypophosphatasia: data from 5 patient-reported outcome measures [PDF]
Eric T Rush, Chad Deal, Steven W InG
exaly +2 more sources
Characterization of tracheobronchomalacia in infants with hypophosphatasia
Background Perinatal and infantile hypophosphatasia (HPP) are associated with respiratory failure and respiratory complications. Effective management of such complications is of key clinical importance.
Raja Padidela +12 more
doaj +1 more source
Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia
Hypophosphatasia (HPP) is the rare, inherited, metabolic bone disease characterized by low activity of the tissue-nonspecific isoenzyme of alkaline phosphatase (TNSALP) leading to excess extracellular inorganic pyrophosphate (PPi) and pyridoxal 5'-phosphate (PLP). Asfotase alfa is the human recombinant enzyme-replacement therapy that replaces deficient
Lothar, Seefried +6 more
openaire +2 more sources
Modern Approaches to the Management of Children with Hypophosphatasia
Hypophosphatasia is rare genetic disease caused by tissue-nonspecific alkaline phosphatase deficiency due to the mutation in the ALPL gene. Disease can manifest in utero, in childhood or in adults depending on its form and severity. This article presents
Aleksander A. Baranov +22 more
doaj +1 more source

